Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#1417 Everolimus (EVE) Safety Profile in Patients (pts) with Advanced G1-G2 Neuroendocrine Tumours (NETs) from Daily Clinical Practice

Introduction: EVE has shown an overall favourable and well-characterized safety profile in randomized studies including advanced G1-G2 NETs. However, few data outside regulatory trials are available.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Carmona-Bayonas A

Authors: Carmona-Bayonas A, Jiménez-Munarriz B, Jimenez-Fonseca P, Custodio A, Alonso V,

Keywords: everolimus,tolerability,

#1413 Everolimus (EVE) Treatment for Advanced G1-G2 Neuroendocrine Tumours (NETs) in the Community Setting: Clinical Benefit Irrespective of Previous Therapies

Introduction: Randomized studies have shown EVE has antitumour activity in advanced G1-G2 NETs. However, data outside regulatory trials are limited.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Custodio A

Authors: Custodio A, Alonso V, Jimenez-Fonseca P, Lopez C, Alonso T,

Keywords: everolimus, previous therapies,

#568 Efficacy of Everolimus and Tolerability with Long-Term Use

Introduction: Predictors of response to Everolimus in neuroendocrine tumors and long-term safety data are lacking.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Heetfeld M, Tischer E, Denecke T, Perez Fernandez C, Wiedenmann B,

Keywords: everolimus, prior therapies, pneumonitis ,